Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors - Concepedia

Concepedia

Publication | Open Access

Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors

DOI Full Paper Access

196

Citations

23

References

2019

Year

Sarina A. Piha‐Paul, Christine L. Hann, Christopher A. French, Sophie Cousin, Irene Braña, Phillippe A. Cassier, Víctor Moreno, Johann S. de Bono, Sara Harward, Geraldine Ferron‐Brady,

JNCI Cancer Spectrum

Abstract

Once-daily molibresib was tolerated at doses demonstrating target engagement. Preliminary data indicate proof-of-concept in NC.

References

	Year	Citations

Page 1